March 23, 2020 / 11:43 AM / 2 months ago

BRIEF-Biohaven Pharmaceutical Says If This Planned Vazegepant Phase 3 Trial Is Positive, Would Have Potential Of Filing An NDA Next Year

March 23 (Reuters) - Biohaven Pharmaceutical Holding Company Ltd:

* BIOHAVEN PHARMACEUTICAL HOLDING COMPANY - IF THIS PLANNED VAZEGEPANT PHASE 3 TRIAL IS POSITIVE, WOULD HAVE POTENTIAL OF FILING AN NDA NEXT YEAR Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below